PATENT CLAIM ANALYSIS

Application Number: 16045400
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["530", "391900"]

Abstract:
The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates.

Claim (Index 23):
The method of  claim 22 , wherein the immunoconjugate is made by reacting the thiol-reactive moiety of the linker-SN38 with a reduced sulfhydryl of the MAb.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.33333
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15587526', '15133675', '15267910', '14636790', '14294651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.731182798083675
- 35 USC 102 Novelty (BERT): 0.6038340896291912
- Combined Prediction Score: 0.7184479272382267
- Mean Citation Score: 482.2731
- Max Citation Score: 507.62848
- Similarity Product: 500.7717864940453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test